Literature DB >> 26136919

Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report.

Shijima Taguchi1, Junichi Furuta2, Gen Ohara3, Katsunori Kagohashi3, Hiroaki Satoh3.   

Abstract

Bronchiolitis is a rare condition mainly affecting the intralobular conducting and transitional small airways. The present study describes a case of severe airflow limitation in a patient with ulcerative colitis who developed toxic epidermal necrolysis following mesalazine therapy. Forced expiratory volume in one second was decreased and a flow-volume curve showed airflow limitation, but the single-breath diffusing capacity of the lung for carbon monoxide (DLCO) and DLCO divided by alveolar volume (DLCO/VA) were not decreased. This rare clinical condition should be considered as a differential diagnosis for subjects presenting with sub-acutely developed airflow obstruction if the findings in chest computed tomography scans demonstrate hyperinflation but few low-attenuation areas. Relatively well-preserved DLCO and DLCO/VA provide a clue to establishing the correct diagnosis.

Entities:  

Keywords:  airflow obstruction; mesalazine; obstructive bronchiolitis; toxic epidermal necrolysis; ulcerative colitis

Year:  2015        PMID: 26136919      PMCID: PMC4471703          DOI: 10.3892/etm.2015.2307

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome.

Authors:  A P Shah; H Xu; P J Sime; D R Trawick
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

2.  Rapidly progressive bronchiolitis obliterans associated with Stevens-Johnson syndrome.

Authors:  N Tsunoda; T Iwanaga; T Saito; S Kitamura; K Saito
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

Review 3.  Pathology of small airways disease.

Authors:  Timothy Craig Allen
Journal:  Arch Pathol Lab Med       Date:  2010-05       Impact factor: 5.534

4.  Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine.

Authors:  Prabath W B Nanayakkara; Evelien de Jong; Piet E Postmus
Journal:  Eur J Intern Med       Date:  2004-11       Impact factor: 4.487

5.  Multiple pulmonary complications in a patient with Stevens-Johnson syndrome.

Authors:  F S Virant; G J Redding; A H Novack
Journal:  Clin Pediatr (Phila)       Date:  1984-07       Impact factor: 1.168

6.  Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease.

Authors:  D D Ralph; S C Springmeyer; K M Sullivan; R C Hackman; R Storb; E D Thomas
Journal:  Am Rev Respir Dis       Date:  1984-04

7.  Pulmonary hemodynamics, gas exchange, and the severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema.

Authors:  W Biernacki; G A Gould; K F Whyte; D C Flenley
Journal:  Am Rev Respir Dis       Date:  1989-06

Review 8.  [Diffuse panbronchioliltis associated with bullous pemphigoid].

Authors:  K Oshikawa; Y Sugiyama; S Kitamura
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1995-09

Review 9.  Bronchiolar disorders.

Authors:  Jay H Ryu; Jeffrey L Myers; Stephen J Swensen
Journal:  Am J Respir Crit Care Med       Date:  2003-12-01       Impact factor: 21.405

10.  Acute eosinophilic pneumonia related to a mesalazine suppository.

Authors:  Jung Hyun Kim; June-Hyuk Lee; Eun-Suk Koh; Sung Woo Park; An-Soo Jang; Dojin Kim; Choon-Sik Park
Journal:  Asia Pac Allergy       Date:  2013-04-26
View more
  2 in total

1.  Chronic pulmonary complications associated with toxic epidermal necrolysis: A case report and literature review.

Authors:  Nuo Xu; Xuehua Chen; Shengdi Wu; Maosong Ye; Meiling Zhang; Lin Tong; Xiaodan Zhu; Jie Liu; Feifei Hu; Chunxue Bai
Journal:  Exp Ther Med       Date:  2018-06-27       Impact factor: 2.447

2.  Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review.

Authors:  Yunjian Zhang; Ling Luo; Xiaofang Wang; Xiaoyang Liu; Xiaoyan Wang; Yi Ding
Journal:  Ther Clin Risk Manag       Date:  2016-06-14       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.